Similar articles

• Successful gene therapy for severe combined immunodeficiency.

  Rosen FS. Rosen FS. N Engl J Med. 2002 Apr 18;346(16):1241-3. doi: 10.1056/NEJM200204183461612. N Engl J Med. 2002. PMID: 11961154 No abstract available.
• Gene therapy. The best of times, the worst of times.

  Anderson WF. Anderson WF. Science. 2000 Apr 28;288(5466):627-9. doi: 10.1126/science.288.5466.627. Science. 2000. PMID: 10799000 No abstract available.
• Gene therapy for primary immunodeficiencies.

  Fischer A, Hacein-Bey Abina S, Touzot F, Cavazzana M. Fischer A, et al. Clin Genet. 2015 Dec;88(6):507-15. doi: 10.1111/cge.12576. Epub 2015 Mar 23. Clin Genet. 2015. PMID: 25708106 Review.
• Gene therapy of severe combined immunodeficiencies.

  Fischer A, Hacein-Bey S, Le Deist F, De Saint Basile G, Cavazzana-Calvo M. Fischer A, et al. Adv Exp Med Biol. 2001;495:199-204. doi: 10.1007/978-1-4615-0685-0_27. Adv Exp Med Biol. 2001. PMID: 11774567 No abstract available.
• Gene therapy of primary T cell immunodeficiencies.

  Fischer A, Hacein-Bey-Abina S, Cavazzana-Calvo M. Fischer A, et al. Gene. 2013 Aug 10;525(2):170-3. doi: 10.1016/j.gene.2013.03.092. Epub 2013 Apr 10. Gene. 2013. PMID: 23583799 Review.